Prescription-only sleep medicine found in children's gummies
The gummies, marketed as a magnesium supplement, were found to contain between 1.5 and 1.7mg of melatonin per individual gummy.
Melatonin, a hormone that regulates the sleep-wake cycle, is a prescription-only medicine in the UK for sleep disorders, with a recommended starting dose of 1mg for children.
The Medicines and Healthcare products Regulatory Agency (MHRA) has advised parents to dispose of the product and is working with online retailers to remove all listings.
Taking too much melatonin can cause side effects including headaches, drowsiness, dizziness, and nausea, and parents are advised to report any suspected adverse reactions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
19 minutes ago
- Daily Mail
Man cured of deadly disease suffered by millions of Americans in first-of-its-kind procedure
A man with type 1 diabetes was cured of the condition after a first-of-its-kind procedure, experts have revealed. The 42-year-old from Sweden was diagnosed with type 1 diabetes at just five years old, which caused his body to not produce enough insulin to control blood sugar. But today he no longer needs daily insulin shots and can finally enjoy sugar without stress, doctors wrote in a medical journal this month. Last year, the man underwent an islet cell transplant, which involves transplanting islet cells into the liver to help the pancreas produce insulin on its own. Islet cells are cells in the pancreas that produce hormones to help regular blood sugar levels. This was done with a series of injections in the man's forearm muscle. Over the next three months, his body responded to the transplanted cells and started to make its own insulin in response to glucose spikes, which usually happen after meals. While islet cell transplants have been performed in a handful of patients, the man was the first to have his islet cells genetically engineered so his body wouldn't reject them. This helped him avoid having to take immunosuppressant drugs, which weaken the body's defense system and leave it vulnerable to dangerous infections. About 1.6million Americans are diagnosed with type 1 diabetes. It's much less common than type 2 diabetes, which affects 32 million Americans and typically comes on later in life due to a confluence of lifestyle factors and genes. Without insulin, type 1 diabetics' bodies have no way to regulate blood sugar, which can build up in the bloodstream and skyrocket. The body starts breaking down fat for fuel, creating ketones, or acidic byproducts. A buildup of ketones in the blood can cause diabetic ketoacidosis, a condition that causes nausea, vomiting, rapid breathing, dehydration, and confusion. Without proper treatment with insulin and fluids, diabetic ketoacidosis can cause a laundry list of potentially fatal effects, including brain swelling, kidney failure, cardiac arrest, and death. Islet cell transplantation involves taking islet cells, which live in the pancreas and produce insulin, from a healthy or deceased donor and injecting them into a person with type 1 diabetes. The unidentified man got his cells from a living donor. Currently, islet cell transplants are estimated to cost around $100,000. Patients normally have to take immunosuppressant drugs for weeks or months after the procedure because the body thinks transplanted cells are foreign and dangerous and will mount the immune system to kill them. The drugs help stop that response and prevent the immune system from attacking the new cells. However, in suppressing the immune system, these drugs leave patients vulnerable to severe infections from something as simple as a cold. To avoid this, the man's transplanted cells were modified with CRISPR, a type of gene editing usually used for cancer patients, to personalize the cells to the man's immune system. The technique had previously only been used in mice and monkeys. After three months, the man's transplanted islet cells began producing insulin without the need for immunosuppressant medications. He had a handful of minor complications like vein inflammation, an infected ulcer on his fingertip, excessive sweating and arm numbness, all of which have subsided. The man is one of a handful of patients to receive an islet cell transplant and essentially be cured of type 1 diabetes. Like the man in the case report, Illinois mother-of-one Marlaina Goedel, 30, was diagnosed with type 1 diabetes at five years old. Within four weeks of the procedure, she no longer had to take insulin. Goedel previously told 'The cure is out there.' Goedel was part of a recent clinical trial involving an islet cell transplant run out of the University of Chicago Medicine Transplant Institute. However, her cells were from a deceased donor, and she did require an immunosuppressant drug after the procedure. She told this website that for the first time in her life, she can ride her horse and spend time with her daughter without worrying about a blood sugar crash. She is also going back to school to become a horse massage therapist. She said: 'It took a while to get used to saying, "I am cured. I am diabetes free. It's been very freeing.
The Independent
21 minutes ago
- The Independent
‘Ozempic for dogs' may be the next big thing in pet health
With the runaway success of drugs like Ozempic and Mounjaro effectively helping humans slim down, researchers and biotech firms are now sniffing out a new frontier: weight-loss drugs for dogs. With up to 60 per cent of dogs in the UK estimated to be overweight or obese, the market for such drugs could be considerable. Okava, a San Francisco-based bio-pharma company which specialises in pet health, is planning to run trials for a drug designed to mimic the effects of Ozempic, with the goal to produce an implant-version for dogs, which lasts six-months at a time. According to estimates on the company's website, the current market for such a product could be worth $10bn, and they hope to have a canine weight-loss drug available as early as 2028 or 2029. In human weight-loss drugs, the active ingredient in Mounjaro is called tirzepatide, and in Ozempic, it is semaglutide. Both work in similar ways, mimicking a natural hormone called GLP-1. This hormone regulates blood sugar and appetite, ultimately leading people to feel fuller longer and reducing food intake. The challenge for biotech firms is to reproduce that effect in dogs – a species well-known for practically limitless gorging. The hope is that an Ozempic-style drug may reduce dogs' begging behaviour, which many owners find it difficult to resist rewarding. Often, lack of appetite in dogs is associated with illness, meaning developing an effective drug that doesn't appear to make pets seem unwell is a fine balance. One such drug, named Slentrol, was launched in 2007, but did not sell well, partly due to how owners' perceived their pets behaviour when on the medication. Okava's planned implant, called OKV-119, contains a GLP-1 mimic called exenatide. Michael Klotsman, Okava's chief executive, said he hoped dogs' behavioural changes from OKV-119 would be quite different from illness-related appetite loss. 'What owners should expect to see is their pet eating appropriate portions without the previous food obsession – they'll still eat regularly and show interest in meals, just without the excessive begging, scavenging or gulping behaviour,' he told The Guardian. But not all tails are wagging. Vets have suggested that in most cases, dog owners would be better off avoiding obesity in their dogs through more exercise and by restricting their pets' diets. Caroline Allen, Chief Veterinary Officer at the RSPCA told The Independent: 'A healthy diet and exercise is the best way to keep our pets happy and well but we understand that owners can sometimes struggle to manage their pets' weight. There is currently little information about proposed weight-loss implants or vaccinations for animals, and owners shouldn't rely on them becoming available. 'Before resorting to these sorts of interventions, owners should seek help from their vet about how to reduce their pet's weight with a good diet and providing lots of opportunities to exercise and play in ways that their pet will enjoy." She added: 'It may be that weight loss jabs or implants may have a role to play in future in very limited circumstances where animals are clinically unwell, but the best thing we can do is set healthy habits from the start so our pets can live the best life possible.'
The Independent
an hour ago
- The Independent
Children's supplement recalled over fears it contains prescription-only sleep drug
A health alert has been issued to parents over a brand of children 's magnesium gummies after batches were found to contain a prescription-only drug used to aid sleep. Melatonin, which may cause drowsiness, headaches, dizziness and nausea, was detected in Kids Magnesium Glycinate Gummies made by Nutrition Ignition. The synthetic hormone is not listed on the packaging of the raspberry-flavoured gummies. Health chiefs have ordered the gummies to be removed from sale, working with online retailers to withdraw all listings. The Medicines and Healthcare products Regulatory Agency (MHRA) has warned parents to stop giving them to children and to safely dispose of any left. According to top US research school John Hopkins Medicine, people should not use melatonin if they have and autoimmune disorder, a seizure disorder or depression. It also says melatonin supplements may raise blood sugar. Experts at the agency, who tested two batches of the supplements, found between 1.5 and 1.7mg of melatonin in each gummy. The usual adult dose of prescription melatonin, to help severe sleep problems or to recover from jet lag, is 2mg. If prescribed for children, the recommended starting dose is 1mg but may be increased to up to 5mg a day. The product packaging advised one or two gummies per day, depending on the child's age. MHRA chiefs say advice should be sought from a healthcare professional if a child has any worrying side effects. According to the NHS, melatonin takes up to two hours to work. It is usually recommended for up to 13 weeks, and anyone taking it for a long time might need help to come off it. But the MHRA says lasting harm is not expected when ingesting melatonin at high levels, and the body typically clears it within 12 hours. Anyone who has the gummies at home is advised to store them in a tamper-proof container until they take it to a pharmacy for disposal. The gummies must now be regulated as a medicine. Nutrition Ignition Kids Magnesium Glycinate Gummies were promoted as supporting 'calm, focus and digestion '. Alison Cave, chief safety officer at the MHRA, said: 'Side-effects such as headache, hyperactivity, a feeling of dizziness and abdominal pain have been reported in children when melatonin is prescribed and used for its licensed indications. No serious side- effects were observed in studies in children. 'Anyone who suspects that their child or a child in their care is having a side-effect from this product is advised to stop taking it and speak to a healthcare professional and report it directly to the MHRA Yellow Card scheme.'
